Related to FDA Clears Avid’s Amyloid Plaque Imaging Agent for Aiding Alzheimer Disease Diagnosis

• FDA Clears MedImmune’s FluMist Quadrivalent Flu Vaccine
  
• FDA Clears Discovery Laboratories’ Drug for Respiratory Distress Syndrome in Infants
  
• RNA Spinach Sensor Tracks Metabolites Not Amenable to Fluorescent Protein Tags
  
• FDA Approves Organogenesis’ Gintuit Cell-Based Product for Gum Disease
  
• Grifols Nabs 51% Stake in Alzheimer Disease Dx, Vaccines Firm Araclon
  
• FDA Clears Affymax and Takeda’s Once-Monthly ESA for Anemic CKD Patients on Dialysis
  
• Abbott Achieves CE Mark for PLEX-ID Microbial Identification Technology, Assays
  
• 2-to-1 Majority of Respondents to a GEN Poll See Smooth Sailing Ahead for Vivus' Obesity Therapy
  
• With Acquisition of Bayer Imaging R&D Portfolio, Piramal Continues Shift to Pharma IP
  
• Takeda’s Type 2 Diabetes Therapies Set Back Again by FDA
  
• FDA Requests More Risk-Benefit Data for Amgen’s Xgeva sBLA in Prostate Cancer
  
• Novartis’ Afinitor Gets FDA Okay for Treating Renal Angiomyolipoma Associated with TSC
  
• GSK’s Votrient Approved in U.S. for Treating Soft Tissue Sarcoma
  
• Protalix, Pfizer Report FDA Approval of Plant-Derived Gaucher Disease ERT Elelyso
  
• Genzyme Gets FDA, EMA Approvals for Production Plant in Waterford, Ireland
  
• Curetis Wins CE Mark for POC Diagnostic Platform, Pneumonia Test Cartridge
  
• IntelligentMDx Wins CE Mark for Group B Strep Assay on Abbott m2000 Instrument
  
• FDA Clears Novo Nordisk’s Levemir for Diabetic Children Aged Two Years and Over
  
• FDA Approves XenoPort, GSK’s Horizant for Managing Postherpetic Neuralgia
  
• FDA Clears Roche’s Perjeta as Combination Therapy for Metastatic Breast Cancer